Common Shares Outstanding: The number of class A shares currently held by investors.
AMNEAL PHARMACEUTICALS, INC. (AMRX) had Common Shares Outstanding of 319.00M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$722.52M |
|
$62.26M |
|
$402.41M |
|
$320.11M |
|
$580.75M |
|
$141.77M |
|
$-61.60M |
|
$80.18M |
|
$80.18M |
|
$78.00M |
|
$78.00M |
|
$78.00M |
|
$78.00M |
|
$141.77M |
|
$188.85M |
|
316.02M |
|
328.93M |
|
$0.20 |
|
$0.19 |
|
| Balance Sheet Financials | |
$1.80B |
|
$444.61M |
|
$1.74B |
|
$3.54B |
|
$728.05M |
|
$2.62B |
|
$2.86B |
|
$3.59B |
|
$-45.97M |
|
$-1.17B |
|
$-45.97M |
|
|
Common Shares Outstanding |
319.00M |
| Cash Flow Statement Financials | |
$-26.74M |
|
$-21.71M |
|
$-59.05M |
|
$312.94M |
|
$204.41M |
|
$-108.53M |
|
$8.82M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.47 |
|
-- |
|
-- |
|
1.02 |
|
-57.22 |
|
44.31% |
|
19.62% |
|
19.62% |
|
-- |
|
11.10% |
|
8.62% |
|
$-40.60M |
|
-- |
|
-- |
|
-- |
|
0.20 |
|
0.63 |
|
0.85 |
|
106.05 |
|
-169.68% |
|
-6.64% |
|
2.20% |
|
3.03% |
|
$-0.14 |
|
$-0.12 |
|
$-0.08 |
|